-
AI Bringing Major Change To The Way Studies Get Conducted
Clinical Research News | Clinical research stakeholders, most especially study sponsors, are now firmly onboard with the idea of using artificial intelligence (AI) to improve the conduct of clinical trials.
Aug 15, 2023
-
Proteins In The Blood Hint At Biological Basis Of Long COVID
Clinical Research News | A point-of-care (POC) diagnostic test for long COVID is under development that would be a godsend to the millions of Americans still suffering the health consequences of SARS-CoV-2 months after being infected.
Aug 11, 2023
-
Ramita Tandon and How Walgreens Is Tackling Disparities in Clinical Trials
Clinical Research News | The COVID-19 pandemic amplified a lot of existing weaknesses in the healthcare system, and clinical research was no exception: less than 5% of the nation partakes in clinical trials and 75% of those participants are white. This disparity indicates that drugs undergoing clinical trials don’t necessarily have the same effect on the rest of the American population, particularly those from ethnic and racial minority groups.
Aug 8, 2023
-
Three Keys to Improving Diversity in Clinical Trials
Clinical Research News | Clinical research should be a viable option for everyone who wishes to participate. Sponsors know that diverse trials lead to stronger data and better drugs, yet there are many obstacles to recruiting and retaining diverse participants – from distrust, to lack of access, to financial and logistical barriers.
Aug 4, 2023
-
Researchers Close In On Protein Panel For Predicting Islet Autoimmunity
Clinical Research News | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.
Aug 3, 2023
-
Mitigating Tactics To Improve The Generalizability Of Pragmatic Trials
Clinical Research News | Randomized controlled trials are a fantastic first step in assessing the clinical effects of medical interventions, but they are not sufficient to transform the “busy throughput environment” of real-world healthcare involving appointment scheduling and referrals, differing practice patterns, and patients with comorbidities and social determinants of health like housing instability and low literacy skills.
Aug 1, 2023